Related references
Note: Only part of the references are listed.Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2
Rogerio Lilenbaum et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy
Nina Helbekkmo et al.
LUNG CANCER (2008)
Statistics in medicine - Reporting of subgroup analyses in clinical trials
Rui Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
N. Helbekkmo et al.
BRITISH JOURNAL OF CANCER (2007)
Symptoms in patients with lung carcinoma - Distinguishing distress from intensity
C Tishelman et al.
CANCER (2005)
Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer
LJ Fallowfield et al.
LUNG CANCER (2005)
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730)
RC Lilenbaum et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group
D Osoba et al.
EUROPEAN JOURNAL OF CANCER (2005)
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
C Gridelli et al.
ANNALS OF ONCOLOGY (2004)
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003
DG Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Challenges in defining and identifying patients with non-small cell lung cancer and poor performance status
K Kelly
SEMINARS IN ONCOLOGY (2004)
Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials
A Bottomley et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?
JC Soria et al.
ANNALS OF ONCOLOGY (2001)
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer
LJ Billingham et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
